Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.9300 (4.63%) ($13.7500 - $15.0600) on Thu. May. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.94% (three month average) | RSI | 85 | Latest Price | $14.9300(4.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 9.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 20.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) IBB(45%) ARKK(43%) IWO(42%) | Factors Impacting ATRA price | ATRA will decline at least -4.47% in a week (0% probabilities). VIXM(-30%) VXX(-27%) UNG(-11%) UUP(-8%) TLT(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.47% (StdDev 8.94%) | Hourly BBV | 0 () | Intraday Trend | 5.4% | | | |
|
5 Day Moving Average | $12.43(20.11%) | 10 Day Moving Average | $11.4(30.96%) | 20 Day Moving Average | $10.08(48.12%) | To recent high | 0% | To recent low | 162.4% | Market Cap | $1.109b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |